Ascendis Pharma A/S
ASND stock score: 63/100
$242.99 · +1.71% · Scored Oct 22, 2026
- Technical
- 64
- Fundamental
- 62
- News
- 53
The reading
Ascendis Pharma A/S (ASND) scores 63 out of 100, which reads neutral, higher than 90% of Healthcare stocks and 83% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 64, fundamentals 62.
Among the fundamentals, Price Target at 100 and Profit Margins at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 62 and contrarian oscillators 39.
News sentiment is neutral at 53; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 55 to 73, and it is down 9 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward ASND’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
62Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Profit Margins100
Profit margins show what percentage of revenue becomes profit.
- Return on Equity (ROE)100
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
Holding it back
- Earnings Quality (Annual)0
Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.
- EV/EBITDA1
EV/EBITDA compares the whole company's value, debt included, with its operating earnings before depreciation.
- Return on Assets (ROA)1
Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.
39 weighted scorers; 2 had no data today and are left out rather than counted as zero.
Technical · daily
57Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- VWAP100
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
- SMA 50 Cross Up100
SMA 50 Cross Up detects when faster averages cross above the 50-period SMA.
Holding it back
- Bollinger Bands (20)0
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- Ichimoku Cloud0
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- Williams %R (14)6
Williams %R (14-period) measures where the current price sits within the recent high-low range.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 53
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 62 | 1 |
| Daily | 57 | 3 |
| Weekly | 62 | 2 |
| Monthly | 70 | 2 |
| Quarterly | 72 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 63 |
| Oct 21, 2026 | 62 |
| Oct 20, 2026 | 60 |
| Oct 19, 2026 | 59 |
| Oct 18, 2026 | 57 |
| Oct 17, 2026 | 57 |
| Oct 16, 2026 | 56 |
| Oct 15, 2026 | 58 |
| Oct 14, 2026 | 57 |
| Oct 13, 2026 | 56 |
| Oct 12, 2026 | 57 |
| Oct 11, 2026 | 58 |
| Oct 10, 2026 | 58 |
| Oct 9, 2026 | 58 |
| Oct 8, 2026 | 56 |
| Oct 7, 2026 | 57 |
| Oct 6, 2026 | 57 |
| Oct 5, 2026 | 57 |
| Oct 4, 2026 | 57 |
| Oct 3, 2026 | 57 |
| Oct 2, 2026 | 57 |
| Oct 1, 2026 | 56 |
| Sep 30, 2026 | 57 |
| Sep 29, 2026 | 57 |
| Sep 28, 2026 | 57 |
| Sep 27, 2026 | 56 |
| Sep 26, 2026 | 56 |
| Sep 25, 2026 | 56 |
| Sep 24, 2026 | 58 |
| Sep 23, 2026 | 57 |
| Sep 22, 2026 | 59 |
| Sep 21, 2026 | 59 |
| Sep 20, 2026 | 58 |
| Sep 19, 2026 | 58 |
| Sep 18, 2026 | 59 |
| Sep 17, 2026 | 59 |
| Sep 16, 2026 | 60 |
| Sep 15, 2026 | 59 |
| Sep 14, 2026 | 65 |
| Sep 13, 2026 | 65 |
| Sep 12, 2026 | 65 |
| Sep 11, 2026 | 65 |
| Sep 10, 2026 | 63 |
| Sep 9, 2026 | 64 |
| Sep 8, 2026 | 66 |
| Sep 7, 2026 | 65 |
| Sep 6, 2026 | 65 |
| Sep 5, 2026 | 65 |
| Sep 4, 2026 | 66 |
| Sep 3, 2026 | 66 |
| Sep 2, 2026 | 66 |
| Sep 1, 2026 | 65 |
| Aug 31, 2026 | 65 |
| Aug 30, 2026 | 61 |
| Aug 29, 2026 | 61 |
| Aug 28, 2026 | 61 |
| Aug 27, 2026 | 61 |
| Aug 26, 2026 | 62 |
| Aug 25, 2026 | 63 |
| Aug 24, 2026 | 63 |
| Aug 23, 2026 | 63 |
| Aug 22, 2026 | 63 |
| Aug 20, 2026 | 64 |
| Aug 19, 2026 | 63 |
| Aug 18, 2026 | 62 |
| Aug 17, 2026 | 60 |
| Aug 16, 2026 | 60 |
| Aug 15, 2026 | 57 |
| Aug 14, 2026 | 58 |
| Aug 13, 2026 | 56 |
| Aug 12, 2026 | 60 |
| Aug 11, 2026 | 58 |
| Aug 10, 2026 | 59 |
| Aug 9, 2026 | 59 |
| Aug 8, 2026 | 59 |
| Aug 7, 2026 | 60 |
| Aug 6, 2026 | 56 |
| Aug 5, 2026 | 56 |
| Aug 3, 2026 | 55 |
| Aug 2, 2026 | 55 |
| Jul 31, 2026 | 73 |
| Jul 30, 2026 | 72 |
| Jul 29, 2026 | 72 |
| Jul 28, 2026 | 72 |
| Jul 27, 2026 | 72 |
| Jul 26, 2026 | 72 |
| Jul 25, 2026 | 72 |
Key facts
- Market cap
- $16.0B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- —
- Risk grade (1–10)
- —
- Next earnings
- —
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| EXEL Exelixis | $16.0B | 73 |
| HALO Halozyme Therapeutics | $14.2B | 70 |
| JAZZ Jazz Pharmaceuticals | $13.8B | 56 |
| BBIO BridgeBio Pharma | $13.2B | 48 |
| SMMT Summit Therapeutics | $12.6B | 43 |
| CORT Corcept Therapeutics | $12.6B | 60 |
Questions
What is ASND's stock score today?
ASND scores 63/100 (Neutral) as of Oct 22, 2026: technical 64, fundamental 62, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.
Is ASND a buy?
The score is not a buy or sell recommendation. A 63 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the ASND score calculated?
100 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.